SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : Receptagen Ltd.
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: jack BROSS who wrote (158)8/7/1998 1:40:00 PM
From: Russell J. Gilbert  Read Replies (2) of 203
 
Jack,
The strategy is simple. Quite simple. First of all let me say I have been in RCG since their inception. Could have sold my initial stock for a very good profit but didn't.
The company was mis-managed from the get-go. No question. In fact, I feel earlier management actions in some areas were highly questionalbe. Those days are gone and so are those people. What is left is some very valuable technology that GRN has the experience and reseouces to bring forth. An independant auditor valued RCG's technology at around $9,000,000.
Another reason I am hot on RCG is George B. He is up to his eyebaals in this and has some heavy $$$$ tied up in this.
As I have said in the past and I'll say it again, as long as the merger goes through, then you can't lose.
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  

HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2025 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News